THC Biomed Intl Ltd
THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under t… Read more
THC Biomed Intl Ltd (THCBF) - Total Assets
Latest total assets as of April 2023: $13.72 Million USD
Based on the latest financial reports, THC Biomed Intl Ltd (THCBF) holds total assets worth $13.72 Million USD as of April 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
THC Biomed Intl Ltd - Total Assets Trend (2001–2022)
This chart illustrates how THC Biomed Intl Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
THC Biomed Intl Ltd - Asset Composition Analysis
Current Asset Composition (July 2022)
THC Biomed Intl Ltd's total assets of $13.72 Million consist of 29.1% current assets and 70.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.3% |
| Accounts Receivable | $440.44K | 3.0% |
| Inventory | $2.79 Million | 18.9% |
| Property, Plant & Equipment | $10.40 Million | 70.6% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2022)
This chart illustrates how THC Biomed Intl Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: THC Biomed Intl Ltd's current assets represent 29.1% of total assets in 2022, a decrease from 84.2% in 2001.
- Cash Position: Cash and equivalents constituted 3.3% of total assets in 2022, down from 5.4% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
- Asset Diversification: The largest asset category is property, plant & equipment at 70.6% of total assets.
THC Biomed Intl Ltd Competitors by Total Assets
Key competitors of THC Biomed Intl Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
THC Biomed Intl Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - THC Biomed Intl Ltd generates 0.17x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - THC Biomed Intl Ltd is currently not profitable relative to its asset base.
THC Biomed Intl Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.41 | 0.93 | 5.00 |
| Quick Ratio | 0.10 | 0.36 | 4.29 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-4.73 Million | $ -404.21K | $ 6.54 Million |
THC Biomed Intl Ltd - Advanced Valuation Insights
This section examines the relationship between THC Biomed Intl Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.05 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -15.2% |
| Total Assets | $14.75 Million |
| Market Capitalization | $116.34K USD |
Valuation Analysis
Below Book Valuation: The market values THC Biomed Intl Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: THC Biomed Intl Ltd's assets decreased by 15.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for THC Biomed Intl Ltd (2001–2022)
The table below shows the annual total assets of THC Biomed Intl Ltd from 2001 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-07-31 | $14.75 Million | -15.23% |
| 2021-07-31 | $17.40 Million | -20.11% |
| 2020-07-31 | $21.77 Million | +20.58% |
| 2019-07-31 | $18.06 Million | +24.71% |
| 2018-07-31 | $14.48 Million | +107.95% |
| 2017-07-31 | $6.96 Million | +334.94% |
| 2016-07-31 | $1.60 Million | +26.32% |
| 2015-07-31 | $1.27 Million | +167.85% |
| 2014-07-31 | $473.18K | +148.79% |
| 2013-07-31 | $190.19K | +338.63% |
| 2012-07-31 | $43.36K | -99.46% |
| 2011-07-31 | $8.01 Million | +1450.03% |
| 2010-07-31 | $516.75K | -85.70% |
| 2009-07-31 | $3.61 Million | -8.70% |
| 2008-07-31 | $3.96 Million | -3.00% |
| 2007-07-31 | $4.08 Million | +35.77% |
| 2006-07-31 | $3.01 Million | -2.79% |
| 2005-07-31 | $3.09 Million | -0.89% |
| 2004-07-31 | $3.12 Million | +119.37% |
| 2003-07-31 | $1.42 Million | +553.17% |
| 2002-07-31 | $217.79K | +869.11% |
| 2001-07-31 | $22.47K | -- |